Titan Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Titan Pharmaceuticals has a total shareholder equity of $6.6M and total debt of $500.0K, which brings its debt-to-equity ratio to 7.5%. Its total assets and total liabilities are $8.1M and $1.4M respectively.
Key information
7.5%
Debt to equity ratio
US$500.00k
Debt
Interest coverage ratio | n/a |
Cash | US$6.76m |
Equity | US$6.64m |
Total liabilities | US$1.44m |
Total assets | US$8.09m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: TN70's short term assets ($8.0M) exceed its short term liabilities ($1.4M).
Long Term Liabilities: TN70 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: TN70 has more cash than its total debt.
Reducing Debt: TN70's debt to equity ratio has reduced from 63.2% to 7.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TN70 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: TN70 has less than a year of cash runway if free cash flow continues to grow at historical rates of 9.1% each year.